New research has found that patients who developed inflammation of the heart, or myocarditis, after receiving an mRNA vaccine for COVID-19 had fewer complications in the 18 months after hospitalization than those who developed it from contracting COVID-19 or some other cause. The population study, conducted in France and published online Monday in JAMA , found that hospital readmission rates, diagnoses of other heart-related conditions, or instances of death were significantly lower in the

Tag-uri: Coronavirus